The United States and the European Union have taken radically different approaches to the regulation of biotechnology and genetically modified organisms (GMOs). This difference in regulatory policy indicates important differences in the ideas that policymakers in the two states hold about appropriate regulation of cutting-edge science, which have been embodied in each state's regulatory framework. Thus, the research question: why was each particular set of ideas able to influence state policy in the U.S. and the EU? I argue that the structure of each state's political institutions privileges different policy-making actors, whose particular ideas then have greater influence over the policy-making process. This paper specifically examines the ideas promoted by state bureaucrats, public-interest groups, and scientific experts.
|Advisor:||Jackson, Patrick Thaddeus|
|School Location:||United States -- District of Columbia|
|Source:||MAI 47/02M, Masters Abstracts International|
|Subjects:||Political science, International law, Environmental science|
|Keywords:||European Union, United States|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be